Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 18:4:2.
doi: 10.12688/aasopenres.13196.3. eCollection 2021.

High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa

Kwadwo Asamoah Kusi  1 , Augustina Frimpong  1 , Frederica Dedo Partey  1 , Helena Lamptey  1 , Linda Eva Amoah  1 , Michael Fokuo Ofori  1
Affiliations
Review

High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa

Kwadwo Asamoah Kusi et al. AAS Open Res. .

Abstract

Following the coronavirus outbreaks described as severe acute respiratory syndrome (SARS) in 2003 and the Middle East respiratory syndrome (MERS) in 2012, the world has again been challenged by yet another corona virus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infections were first detected in a Chinese Province in December 2019 and then declared a pandemic by the World Health Organization in March 2020. An infection caused by SARS-CoV-2 may result in asymptomatic, uncomplicated or fatal coronavirus disease 2019 (COVID-19). Fatal disease has been linked with the uncontrolled "cytokine storm" manifesting with complications mostly in people with underlying cardiovascular and pulmonary disease conditions. The severity of COVID-19 disease and the associated mortality has been disproportionately lower in terms of number of cases and deaths in Africa and also Asia in comparison to Europe and North America. Also, persons of colour residing in Europe and North America have been identified as a highly susceptible population due to a combination of several socioeconomic factors and poor access to quality healthcare. Interestingly, this has not been the case in sub-Saharan Africa where majority of the population are even more deprived of the aforementioned factors. On the contrary, sub-Saharan Africa has recorded the lowest levels of mortality and morbidity associated with the disease, and an overwhelming proportion of infections are asymptomatic. Whilst it can be argued that these lower number of cases in Africa may be due to challenges associated with the diagnosis of the disease such as lack of trained personnel and infrastructure, the number of persons who get infected and develop symptoms is proportionally lower than those who are asymptomatic, including asymptomatic cases that are never diagnosed. This review discusses the most probable reasons for the significantly fewer cases of severe COVID-19 disease and deaths in sub-Saharan Africa.

Keywords: Africa; COVID-19; SARS-CoV-2; immunity; tolerance; trained immunity.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

References

    1. Carod-Artal FJ: Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70(9):311–322. 10.33588/rn.7009.2020179 - DOI - PubMed
    1. Chen Y, Liu Q, Guo D: Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. 10.1002/jmv.25681 - DOI - PMC - PubMed
    1. Du L, He Y, Zhou Y, et al. : The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226–36. 10.1038/nrmicro2090 - DOI - PMC - PubMed
    1. Wrapp D, Wang N, Corbett KS, et al. : Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. 10.1126/science.abb2507 - DOI - PMC - PubMed
    1. Du L, Yang Y, Zhou Y, et al. : MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets. 2017;21(2):131–143. 10.1080/14728222.2017.1271415 - DOI - PMC - PubMed